HELE

Analyst Note: HELE (Helen of Troy Limited)

Date: 2026-06-13 Current Price: $26.47

1. Structural Readiness

• State: Context-Only (No active technical structure defined in the provided data)
• Conservative Entry: —
• Breakout Level: —
• Current Price: $26.47
• Extension: —
• ATR Context: 6.3% (Very High). This indicates elevated volatility, which typically requires wider stops or smaller position sizing if a structure were to form, but currently serves only as a volatility context input.

2. Thesis Layer

This is a TACTICAL, setup-led name with NO named macro thesis at this date. There is no secular theme (e.g., "AI Infrastructure," "Green Energy Transition") explicitly attached to HELE in the provided evidence. The investment case must be judged strictly on the quality of the operational setup (margin inflection via supply chain restructuring and acquisition integration) and the fundamental business metrics provided. Do not invent a thesis; the conviction rests on the execution of the "Margin Inflector" archetype.

3. The Business

Helen of Troy Limited is a global consumer products enterprise operating across the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. The company markets a diverse array of goods through an extensive distribution network encompassing mass merchandisers, drugstore chains, warehouse clubs, home improvement centers, grocery stores, specialty retailers, beauty supply outlets, e-commerce platforms, and direct-to-consumer channels.

Segment Structure: As of November 30, 2025, the company operates two reportable segments:

• Home & Outdoor: Provides household essentials including kitchen tools, storage, cleaning items, baby feeding/nursery products, insulated drinkware (e.g., Hydro Flask), and technical outdoor gear (e.g., Osprey backpacks).
• Beauty & Wellness: Focuses on hair care (styling tools, brushes, shampoos), health monitoring devices (thermometers, blood pressure monitors), and air/water quality appliances (e.g., Braun, Vicks, Honeywell, Drybar, Curlsmith).

Key Operational Highlights (as of Q1 FY2026):

• Acquisition Integration: On December 16, 2024, the company completed the acquisition of Olive & June, an omni-channel nail care brand. The total purchase consideration was $224.7 million (net of cash acquired and adjustments), with up to $15.0 million in contingent cash consideration tied to performance through 2027.
• Growth Driver: Olive & June contributed 4.9 percentage points of growth to total segment sales in the period ended November 30, 2025, driven by 18% organic growth, effective digital marketing, and strong brand loyalty.
• Brand Portfolio: Notable brands include OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools, Drybar, Curlsmith, Revlon, and Bed Head.
• Customer Concentration: Sales to the two largest customers accounted for approximately 33% of consolidated net sales revenue in fiscal 2026.
• Geographic Exposure: Approximately 73% of consolidated net sales revenue was from U.S. shipments during the three months ended November 30, 2025.

4. Archetype and Conviction

Archetype: Margin Inflector Fit: The company fits the "Margin Inflector" archetype due to its active management of cost of goods sold (COGS) through supply chain diversification and the integration of high-growth acquisitions.

Fundamental Context:

• Tariff Mitigation: Management expects to reduce the cost of goods sold exposed to China tariffs to less than 20% by the end of Fiscal 2027. In fiscal 2026, COGS included $50.7 million of additional pre-tax costs related to tariffs. Management expects the net operating income impact to be limited to less than $10 million for the full fiscal year 2027.
• Guidance (Recorded as of April 23, 2026):
• Net Sales: Expected range of $1.751 billion to $1.822 billion.
• Segment Breakdown: Home & Outdoor ($854M–$882M); Beauty & Wellness ($897M–$940M).
• Adjusted EPS: Expected range of $3.25 to $3.75.
• Free Cash Flow: Expected range of $85 million to $100 million.
• Growth Trajectory: Management expects first-half year-over-year sales growth to be slightly positive, with the second half slightly negative.
• Valuation Context: The financial spine indicates a forward consensus EPS of $3.43 for FY1 and $3.52 for FY2.

Conviction Stack:

• Thesis Strength: Moderate. The "Margin Inflector" thesis is supported by concrete management guidance on tariff mitigation and specific acquisition performance (Olive & June).
• Evidence Quality: High. The evidence includes specific earnings transcript quotes and SEC filing data regarding acquisition costs, tariff impacts, and segment performance.
• Structural Quality: Unknown. The technical structure (coils, pivots) is missing from the data, preventing a full assessment of structural quality.
• Setup Readiness: Low/Null. Without PL levels, the setup is not actionable.
• Rerating Potential: Dependent on the successful execution of the tariff mitigation plan and the sustained growth of the Beauty & Wellness segment.

5. Invalidations, Strengtheners, and Gaps

What Would Invalidate the Case:

• Tariff Impact: If the net operating income impact from tariffs exceeds the $10 million guidance for fiscal 2027, or if the reduction of China-exposed COGS to <20% is not achieved by the end of FY2027.
• Acquisition Failure: If Olive & June fails to maintain its 18% organic growth rate or if the contingent consideration triggers significant downside adjustments.
• Customer Concentration: A material loss of one of the top two customers (currently 33% of sales) would be a significant negative signal.

What Would Strengthen the Case:

• Margin Expansion: Confirmation that the supply chain diversification is reducing COGS faster than anticipated, leading to EPS beats within the $3.25–$3.75 range.
• Acquisition Synergy: Further evidence of Olive & June contributing to total segment sales growth beyond the 4.9 percentage points already recorded.
• Tariff Mitigation: Successful replacement of the supply chain planning system in fiscal 2027 (planned) leading to reduced exposure.

Gaps in Evidence:

• Debt/Capital Structure: While acquisition costs are noted, the full impact on the balance sheet (leverage ratios) is not detailed in the provided snippets.
• Competitive Landscape: No specific data on competitor pricing or market share shifts is provided.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: medium Key evidence: Management guidance for FY2026 EPS of $3.25-$3.75 and FCF of $85M-$100M; Olive & June acquisition driving 4.9pp of segment growth; Tariff mitigation plan targeting <20% China exposure by FY2027. Key risks: Tariff costs exceeding $10M net operating income impact; Customer concentration risk with top two clients representing 33% of sales; Volatility in second-half sales growth which is expected to be slightly negative. Sizing hint: Position size should be conservative given the "Very High" ATR (6.3%) and lack of technical entry signal; wait for structural confirmation. Expected path: Management executes supply chain diversification to reduce tariff exposure; Olive & June continues to drive Beauty & Wellness growth; EPS remains within the guided range. Expected horizon: 12 to 18 months for the tariff mitigation plan to fully materialize and for the acquisition synergy to stabilize. Failure mode to watch: A close below the implied support of the acquisition price or a miss on the $10M tariff impact cap that forces a guidance reduction.